MSFT
65
-3
IVZ
46
-2
UAL
45
-3
KO
52
-8
HPE
50
-16
NRG
82
2
ESS
25
-3
PFE
45
16
PPL
69
2
PEP
39
12
MAC
47
-3
CMA
52
-3
ADP
74
-2
A
44
-2
T
65
3
KMB
50
2
BWA
50
-2
AMAT
54
-4
EW
36
2
KSS
36
-5
MSFT
65
-3
IVZ
46
-2
UAL
45
-3
KO
52
-8
HPE
50
-16
NRG
82
2
ESS
25
-3
PFE
45
16
PPL
69
2
PEP
39
12
MAC
47
-3
CMA
52
-3
ADP
74
-2
A
44
-2
T
65
3
KMB
50
2
BWA
50
-2
AMAT
54
-4
EW
36
2
KSS
36
-5
Financhill
Back

GeneDx Holdings Stock Predictions

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Buy
58

WGS
GeneDx Holdings

Last Price:
$70.00
Seasonality Move:
-6.92%

7 Day Trial

ALL ACCESS PASS

$ 7

The Future of Housing Is Being Built Now

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

GeneDx Holdings Stock Forecast

  • Over the next 52 weeks, GeneDx Holdings has on average historically risen by 68.3% based on the past 4 years of stock performance.
  • GeneDx Holdings has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is GeneDx Holdings Stock Undervalued?
    The current GeneDx Holdings [WGS] share price is $71.60. The Score for WGS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • WGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will GeneDx Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, GeneDx Holdings has on average historically risen by 68.3% based on the past 4 years of stock performance.

GeneDx Holdings Stock Rating

Buy
58
GeneDx Holdings (WGS) is a Buy

Is GeneDx Holdings overpriced?

  • GeneDx Holdings has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

GeneDx Holdings Stock Price History

Is WGS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
genedx.com

52-Week Data

52-Week High:
117.75
52-Week Low:
19.49

Prediction Charts

Market Cap:
2B
Price in USD:
71.60
Volume:
660.8K
Beta:
1.89

Technical Analysis

SMA50:
84.89
SMA100:
84.19
SMA200:
69.78
52-Wk Change:
263.08%

Stock Predictions

  • Is GeneDx Holdings stock public?
    Yes, GeneDx Holdings is a publicly traded company.
  • What is the GeneDx Holdings stock quote today?
    The GeneDx Holdings stock price is 71.60 USD today.
  • How to buy GeneDx Holdings stock online?
    You can buy GeneDx Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 64.46 63.27 65.60 60.47
May-7 63.60 57.34 64.16 56.18
May-8 58.00 56.36 58.00 55.17
May-9 59.00 59.14 62.48 58.03
May-12 62.03 59.00 63.00 58.14
May-13 60.56 60.93 62.77 58.64
May-14 60.93 59.45 62.00 59.11
May-15 60.73 63.61 64.55 58.28
May-16 64.90 68.31 69.44 63.15
May-19 67.83 71.02 71.86 66.51
May-20 70.87 72.11 72.38 67.91
May-21 72.11 67.78 73.57 67.26
May-22 67.95 67.33 69.41 67.00
May-23 66.26 71.60 71.63 65.00

GeneDx Holdings Earnings

GeneDx Holdings Earnings Report: Per Share GeneDx Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

GeneDx Holdings Forecast Revenue Growth

GeneDx Holdings Stock Analysis: Historical quarterly revenues per share for GeneDx Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $0.86 per share.

* GeneDx Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.